📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-18 18:34
646 analysed today
646
Today
133,535
All-time analysed
40,118
Positive
6,284
Negative
79,315
Neutral
7,750
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
39 announcements match the current filters (relevance ≥ 5).
Balrampur Chini Q1 Concall: Rs 2,180 Cr Spent on PLA Project; Commissioning by Dec
Balrampur Chini Mills released its Q1 concall transcript detailing sugar operational trends and its strategic Polylactic Acid (PLA) diversification. The company reported holding 45.67 lakh quintals of sugar inventory as of June 30 at an average carrying cost of Rs 37.19 per kg, which stands to benefit from firm domestic sugar prices. On its 80,000-tonne PLA plant, cumulative capex reached Rs 2,180 crore by July-end, with lactic acid commissioning targeted for October and PLA for December. Management guided for approximately 40% average capacity utilization in PLA between January and March.
Confidence: HIGH
What changedBalrampur Chini disclosed detailed operational timelines for its PLA plant commissioning (Oct/Dec) and inventory carrying valuations.
Why it mattersThe Rs 2,180+ crore bioplastic project represents a major long-term diversification from cyclical sugar into high-value green chemicals, while firm domestic sugar prices support near-term inventory margins.
PLA Capex Incurred (by July): INR 2,180 crorePLA Plant Capacity: 80,000 tonnesSugar Inventory (as of June 30): 45.67 lakh quintalsInventory Carrying Cost: INR 37.19 per kgCapex Spent vs Net Worth: ~56%
📅 Short termStable to positive sentiment supported by firm domestic sugar prices and clear milestones on PLA commissioning.
📈 Long termSuccessful commercial scale-up of the PLA plant could structurally de-risk the company from sugar cyclicity and boost margin profiles.
⚠ Risk flags
- Execution and ramp-up risks associated with the new bioplastics (PLA) technology
- Government policy uncertainties regarding sugar export quotas and ethanol diversion restrictions
Key Highlights
Invested Rs 2,180 crore in the 80,000-tonne PLA bioplastics project by the end of July
Lactic acid commissioning slated for October and PLA plant commissioning scheduled for December
Carried 45.67 lakh quintals of sugar inventory at an average carrying cost of Rs 37.19/kg as of June 30
Management targets ~40% average capacity utilization for the PLA plant during Jan-March period
👀 What to Watch
Track the commissioning of the lactic acid unit in October and PLA plant in December, along with government policy updates regarding ethanol diversion rules in September-October.
Q1 FY27 Revenue Up 6% to ₹1637 Cr; PLA Project Capex Revised to ₹3080 Cr
Balrampur Chini Mills (BCML) reported a 6.1% YoY revenue growth in Q1 FY27, reaching ₹1636.79 Cr, supported by higher sugar realizations and distillery volumes. However, consolidated PBT declined to ₹58.53 Cr from ₹73.08 Cr YoY, impacted by compressed ethanol margins and higher operating expenses. A major update is the revision of the Polylactic Acid (PLA) project capex to ~₹3080 Cr (approx. 49% of TTM revenue), with operations expected to commence in H2 FY27. The company maintains a strong liquidity position with its investment in associate Auxilo Finserve valued at ₹959.40 Cr.
Confidence: HIGH
What changedRevenue grew 6% YoY but margins were pressured; the strategic PLA project capex was significantly revised upward to ₹3080 Cr.
Why it mattersThe company is transitioning from a cyclical sugar player to a bio-based materials company; the success of the ₹3080 Cr PLA project is critical for long-term value creation and debt servicing.
Q1 FY27 Revenue: ₹1636.79 CrPLA Project Capex: ₹3080 CrCapex vs TTM Revenue: ~49.1%Sugar Realization: ₹41.55/kgPLA Debt: ₹1086 CrAuxilo Investment Value: ₹959.40 Cr
📅 Short termThe stock may see neutral to slightly cautious sentiment due to the PBT decline and the increased capex requirement for the PLA project.
📈 Long termThe structural shift into bioplastics (PLA) could significantly re-rate the company if successfully executed by H2 FY27, diversifying away from sugar cycle volatility.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Execution risk for the large-scale PLA project
- Increased debt burden for expansion
- Regulatory risk regarding ethanol pricing and sugar export quotas
Key Highlights
Sugar realization increased to ₹41.55 per kg in Q1 FY27 from ₹40.63 per kg in Q1 FY26.
Revised capex for the 80,000-ton PLA plant stands at ~₹3080 Cr, up from previous estimates.
Distillery segment revenue grew 16.9% YoY to ₹539.62 Cr driven by higher volumes.
Sugar inventory as of June 30, 2026, stood at 45.67 lakh quintals valued at ₹37.19/kg.
Long-term borrowings for the PLA project have reached ₹1086.00 Cr as of June 2026.
👀 What to Watch
Investors should closely monitor the execution and commissioning timeline of the PLA plant in H2 FY27, as it represents a significant business model shift. Additionally, watch for any government revisions to ethanol prices for Juice and B-heavy routes which have been stagnant for three years.
Balrampur Chini Appoints Ex-EIL CMD Vartika Shukla; Q1 Revenue Rises 6% to ₹1,636.8 Cr
Balrampur Chini has appointed Ms. Vartika Shukla, former CMD of Engineers India Limited (EIL), as an Independent Director for a 5-year term starting August 11, 2026. The company also reported Q1 FY27 standalone revenue of ₹1,636.79 Cr, up 6.1% YoY, though net profit declined to ₹38.59 Cr from ₹43.09 Cr in the previous year's quarter. The company is actively deploying capital for its ₹2,000 Cr Polylactic Acid (PLA) project, utilizing ₹170.74 Cr from recent fundraise proceeds during the quarter. Ms. Shukla's expertise in mega-project implementation is highly relevant to this bioplastic diversification.
Confidence: HIGH
What changedAppointment of a new Independent Director with deep energy and engineering consultancy experience alongside the release of Q1 FY27 results.
Why it mattersThe appointment of a leader who managed US$100 billion in energy projects at EIL strengthens the board's oversight for Balrampur's ₹2,000 Cr diversification into the bioplastics (PLA) market.
Q1 FY27 Revenue: ₹1636.79 CrQ1 FY27 Net Profit: ₹38.59 CrPLA Project Investment: ₹2000 CrQ1 Revenue vs TTM Revenue: 26.1%PLA Project vs Net Worth: 51.4%
📅 Short termThe market may focus on the slight YoY profit dip in Q1, but the high-caliber board appointment provides a positive signal regarding project execution capabilities.
📈 Long termThe addition of specialized leadership for the PLA project is structurally significant as the company pivots from a cyclical sugar business to a high-growth bio-based chemicals segment.
⚠ Risk flags
- Seasonal volatility in sugar crushing
- Execution risk of the large-scale ₹2,000 Cr PLA project
Key Highlights
Appointment of Ms. Vartika Shukla (ex-CMD, EIL) for a 5-year term until August 10, 2031
Q1 FY27 Standalone Revenue grew 6.1% YoY to ₹1,636.79 Cr
Standalone Net Profit for Q1 FY27 reported at ₹38.59 Cr vs ₹43.09 Cr YoY
Utilized ₹170.74 Cr out of ₹450 Cr raised via securities issuance for project objects
Distillery segment revenue contributed ₹539.62 Cr to the quarterly top line
👀 What to Watch
Monitor the execution timeline of the ₹2,000 Cr PLA project and the impact of Ms. Shukla's engineering expertise on the company's transition into bioplastics.
Q1 Revenue Rs 1636.8 Cr, PAT Rs 38.6 Cr; Vartika Shukla Appointed as Independent Director
Balrampur Chini reported a 6.1% YoY revenue growth to Rs 1636.8 Cr for Q1 FY27, though Net Profit (PAT) declined 10.4% to Rs 38.6 Cr compared to the same quarter last year. The distillery segment remains the primary profit driver with a PBIT of Rs 80.4 Cr, significantly outperforming the sugar segment's PBIT of Rs 38.8 Cr. The company has utilized Rs 170.7 Cr of its recent Rs 450 Cr fundraise, primarily for its strategic Polylactic Acid (PLA) project. Additionally, the appointment of Ms. Vartika Shukla (former CMD of Engineers India Ltd) to the board adds significant project management expertise for their upcoming Rs 2,000 Cr capex cycle.
Confidence: HIGH
What changedThe company reported its Q1 FY27 financial results and strengthened its board by appointing Ms. Vartika Shukla as an Independent Director for a 5-year term.
Why it mattersThe results highlight the company's increasing reliance on the distillery segment for profits as sugar margins face pressure. The board appointment is strategically significant given the company's massive diversification into bioplastics (PLA), requiring high-level engineering and project management oversight.
Q1 Revenue: Rs 1636.79 CrQ1 PAT: Rs 38.59 CrDistillery PBIT: Rs 80.38 CrSugar PBIT: Rs 38.76 CrUnutilized Issue Proceeds: Rs 279.26 Cr
📅 Short termThe stock may see neutral to slightly cautious sentiment due to the YoY decline in PAT and margin pressure in the sugar segment.
📈 Long termThe structural shift toward a bio-based chemical and ethanol-heavy model is intact, with the PLA project being the key long-term value driver.
⚠ Risk flags
- Seasonality of sugar production
- Regulatory risks regarding ethanol blending and pricing
- Execution risk for the large-scale PLA project
Key Highlights
Revenue from operations increased 6.1% YoY to Rs 1636.79 Cr from Rs 1542.27 Cr.
Net Profit (PAT) for the quarter stood at Rs 38.59 Cr, down 10.4% from Rs 43.09 Cr in Q1 FY26.
Distillery segment PBIT of Rs 80.38 Cr remains the core profit contributor, while Sugar PBIT fell to Rs 38.76 Cr.
Utilized Rs 170.74 Cr out of Rs 450 Cr raised through equity issuance for project-related objects.
Polylactic Acid (PLA) segment reported a segment loss of Rs 9.84 Cr, reflecting the pre-operational/investment phase.
👀 What to Watch
Monitor the execution timeline of the Rs 2,000 Cr PLA project and the impact of government ethanol pricing policies on distillery margins. Investors should also track sugar recovery rates in the upcoming crushing season to see if sugar segment profitability stabilizes.
Balrampur Chini Promotes PLA Bioplastics via 'Bioyug On Wheels' Campaign in Rajkot
Balrampur Chini Mills (BCML) is actively conducting a nationwide awareness campaign, 'Bioyug on Wheels,' to support its upcoming Polylactic Acid (PLA) bioplastic vertical. The company is investing over ₹2,000 Cr into this project, which represents approximately 17.2% of its current market cap and is a significant diversification from its core sugar business. The campaign highlights the environmental benefits of PLA, citing a study where microplastics reduced from 287 to 18 particles/kg in 180 days under Indian soil conditions. This initiative is part of BCML's strategy to establish India's first 80,000 TPA PLA plant.
Confidence: HIGH
What changedBCML has transitioned from the investment phase to active market development and consumer awareness for its new 'Bioyug' bioplastic brand.
Why it mattersThe PLA project is a strategic pivot to reduce dependence on cyclical sugar and regulated ethanol markets, moving toward high-margin, sustainable bio-based chemicals.
PLA Project Investment: ₹2,000 CrPLA Plant Capacity: 80,000 TPAInvestment vs Market Cap: ~17.2%Microplastic Reduction (180 days): 93.7%Current Sugar Crushing Capacity: 80,000 TCD
📅 Short termThe announcement is sentiment-positive as it shows progress in market-seeding for the new vertical, though no immediate impact on P&L is expected until the plant is operational.
📈 Long termThe PLA vertical represents a structural shift in BCML's business model, potentially improving margins and providing a hedge against sugar industry volatility.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Execution risk for the first-of-its-kind PLA plant in India
- Market adoption rates for bioplastics vs cheaper conventional plastics
Key Highlights
Investing over ₹2,000 Cr in a new Polylactic Acid (PLA) bioplastic project
Setting up India's first PLA plant with a capacity of 80,000 TPA
PLA microplastics shown to reduce from 287 to 18 particles/kg within 180 days in Indian soil
Campaign engaged over 500 visitors in Rajkot, including municipal officials and manufacturers
Diversification aims to drive a 20% expected growth rate by entering the global bioplastics market
👀 What to Watch
Monitor the execution timeline and commissioning date of the 80,000 TPA PLA plant, as this ₹2,000 Cr investment is the primary catalyst for the company's long-term re-rating.
93.16 Lakh Shares Get Trading Approval Following Rs 450 Cr Preferential Issue
Balrampur Chini Mills has received final trading approval for 93,16,771 equity shares issued on a preferential basis to both promoters and non-promoters. The shares were issued at Rs 483 per share, amounting to a total capital infusion of approximately Rs 450 crore. This fundraise represents roughly 4.1% of the company's current market capitalization and 11.6% of its net worth. The new shares will be available for trading starting July 1, 2026, with staggered lock-in periods for the allottees.
Confidence: HIGH
What changedThe company has completed the regulatory and listing formalities for a preferential allotment of shares, resulting in an immediate increase in its equity base and cash reserves.
Why it mattersThis capital infusion strengthens the balance sheet and provides necessary funding for the company's strategic shift from traditional sugar/ethanol into high-growth bioplastics, while signaling promoter confidence through their participation.
Total Shares Issued: 93,16,771Issue Price: Rs 483Estimated Fundraise Value: Rs 450 CrValue vs Net Worth: ~11.6%Value vs Market Cap: ~4.1%
📅 Short termThe market is likely to view the successful listing and capital infusion positively, though the minor equity dilution (approx. 4.6%) may be factored into the share price over the coming weeks.
📈 Long termThe additional capital supports the company's long-term diversification strategy into sustainable plastics, which could potentially re-rate the business by reducing its reliance on cyclical sugar prices.
⚠ Risk flags
- Equity dilution of approximately 4.6%
- Execution risk associated with the large-scale PLA project
Key Highlights
93,16,771 equity shares of Re 1 face value approved for trading effective July 1, 2026
Issue price set at Rs 483 per share, including a premium of Rs 482
Total fundraise value calculated at approximately Rs 450 crore
Lock-in period for 39,95,864 shares extends until December 31, 2027
Lock-in period for the remaining 53,20,907 shares extends until December 31, 2026
👀 What to Watch
Investors should track the deployment of these funds toward the company's ambitious Rs 2,000 Cr Polylactic Acid (PLA) bioplastic project and monitor for any changes in promoter holding in the upcoming quarterly filings.
Balrampur Chini Receives Listing Approval for 93.16 Lakh Shares at Rs 483 Each
Balrampur Chini Mills has received formal listing approval from both NSE and BSE for 93,16,771 equity shares issued on a preferential basis. These shares were allotted to both promoters and non-promoters at a price of Rs. 483 per share, which includes a significant premium of Rs. 482. The receipt of this approval marks the final regulatory step before these shares become tradable on the exchanges. This capital infusion at a specific price point demonstrates strong internal and external backing for the company's growth prospects.
Key Highlights
Listing approval granted for 93,16,771 equity shares with a face value of Re. 1 each.
Shares issued at a price of Rs. 483 per share, including a premium of Rs. 482.
The preferential allotment includes participation from both Promoters and Non-promoters.
Approvals received from NSE and BSE on June 23, 2026, following the earlier allotment process.
Trading will commence once confirmation of credit is received from NSDL and CDSL.
👀 What to Watch
The promoter participation in this preferential issue at Rs. 483 is a positive signal of confidence in the company's valuation. Investors should monitor the company's upcoming quarterly results to see how this capital is deployed for expansion or debt reduction.
BCML Reports FY26 Revenue of ₹6,271 Cr; Diversifies into ₹80,000 TPA Bioplastic Project
Balrampur Chini Mills Limited (BCML) has reported a robust financial performance for FY26 with revenue of ₹6,271 crore and an EBITDA of ₹741 crore. The company is aggressively diversifying into the bioplastics sector with a 250 TPD (80,000 TPA) Poly Lactic Acid (PLA) plant under implementation at its Kumbhi unit. BCML continues to reward shareholders, having returned ₹1,664.69 crore through buybacks and dividends over the last decade, including a ₹3.50 per share interim dividend in Q2FY26.
Key Highlights
Achieved FY26 Revenue of ₹6,271 crore and EBITDA of ₹741 crore.
Implementing India's first industrial bio-polymer plant for PLA with a capacity of 80,000 TPA.
Maintains a massive integrated capacity of 80,000 TCD sugar crushing and 1,050 KLPD distillery.
Cumulative shareholder returns of ₹1,009.49 crore via buybacks and ₹655.20 crore via dividends over 10 years.
Strategic shift towards a bio-based economy aligned with the Government's BioE3 Policy.
👀 What to Watch
Investors should view BCML as a long-term play on the bio-economy, moving beyond traditional sugar cycles. Monitor the execution timelines of the PLA project as it could significantly re-rate the company's valuation through higher-margin value-added products.
Balrampur Chini Approves ₹450 Crore Fundraise via Preferential Issue to Promoters and Investors
Balrampur Chini Mills Limited has approved the issuance of up to 93,16,771 equity shares on a preferential basis to raise approximately ₹450 crores. The shares are priced at ₹483 each, which includes a premium of ₹482 per share. The allotment includes a mix of promoters, such as Vivek Saraogi who is investing ₹115.92 crores, and marquee institutional investors like Tata Small Cap Fund and ICICI Prudential. This capital infusion is expected to strengthen the company's financial position for its stated strategic objectives.
Key Highlights
Approved the issuance of 93,16,771 equity shares at a price of ₹483 per share (Face Value ₹1).
Total capital to be raised amounts to ₹450,00,00,393 from promoters and institutional investors.
Promoter Vivek Saraogi and Promoter Group (Meenakshi Mercantiles) to contribute over ₹176 crores combined.
Significant institutional participation from Tata Small Cap Fund (₹100 Cr) and 360 One Pipe Fund (₹88 Cr).
The relevant date for determining the floor price was set as April 20, 2026.
👀 What to Watch
Investors should take note of the strong institutional interest and promoter participation at ₹483 per share as a vote of confidence in the company's valuation. Monitor the deployment of these funds toward growth projects or debt reduction in future earnings calls.
BCML Launches Bioplastics Initiative; Setting Up India's First 80,000 TPA PLA Plant
Balrampur Chini Mills (BCML) has formally launched its bioplastics initiative, 'Bioyug Green Command 2026,' marking a strategic entry into the sustainable materials market. The company is in the process of setting up India's first Polylactic Acid (PLA) plant with a capacity of 80,000 TPA, utilizing its sugarcane feedstock. This diversification beyond sugar and distillery operations is supported by high-level government interest and aims to capitalize on the growing global bioplastics market. The initiative also includes the company's first institutional order for compostable products from the Lucknow Cantonment Board.
Key Highlights
Establishing India's first integrated Polylactic Acid (PLA) bioplastic plant with 80,000 TPA capacity.
Secured first institutional order for compostable PLA-based products from the Lucknow Cantonment Board.
Strategic diversification leveraging existing 80,000 TCD sugar crushing capacity for bioplastic feedstock.
Projected global bioplastic market value estimated to reach $120 billion by 2075-2090.
Launch of 'Balrampur Bioyug Bioplastic 3D Printing Project' for skill development in Lakhimpur Kheri.
👀 What to Watch
Investors should view this as a significant long-term value driver that de-risks the company from cyclical sugar prices by moving into high-margin sustainable materials. Monitor the capital expenditure and commissioning timeline of the 80,000 TPA PLA plant as it will be the primary catalyst for revenue diversification.
Balrampur Chini Allots 93.16 Lakh Shares via Preferential Issue to Raise ₹450 Crore
Balrampur Chini Mills has successfully completed the allotment of 93,16,771 equity shares at a price of ₹483 per share, raising a total of ₹450 crore. The issue saw significant participation from the promoter group, including Vivek Saraogi and Sumedha Saraogi, who together with Meenakshi Mercantiles Limited subscribed to nearly 43% of the allotment. Marquee institutional investors such as TATA Small Cap Fund, 360 One Pipe Fund, and various schemes of ICICI Prudential and Alchemy also participated. This move increases the company's paid-up equity capital from ₹20.20 crore to ₹21.13 crore.
Key Highlights
Allotted 93,16,771 equity shares at ₹483 per share (including a premium of ₹482).
Total capital raised through the preferential issue amounts to ₹450,00,00,393.
Promoter group subscribed to 39,95,864 shares, demonstrating strong internal confidence.
Institutional participation led by TATA Small Cap Fund (20.70 lakh shares) and 360 One Pipe Fund (18.22 lakh shares).
Post-allotment, the total paid-up equity share capital stands at 21,12,67,207 shares.
👀 What to Watch
The significant participation by promoters and reputable institutional funds at ₹483 per share is a strong signal of confidence in the company's valuation and growth trajectory. Investors should monitor how the company utilizes this ₹450 crore capital for future expansion or debt management.
Balrampur Chini Gets Approval for Preferential Issue of 93.16 Lakh Shares at Rs 483/Share
Balrampur Chini Mills Limited has received in-principle approval from both NSE and BSE for the preferential allotment of up to 93,16,771 equity shares. The shares, with a face value of Re 1, are priced at Rs 483 each, including a premium of Rs 482. This move is set to raise approximately Rs 450 crore in cash for the company. The approval is subject to standard regulatory conditions and compliance with SEBI (ICDR) and (LODR) regulations.
Key Highlights
Received in-principle approval for the issuance of up to 93,16,771 equity shares on a preferential basis.
Issue price is fixed at Rs 483 per share, which includes a significant premium of Rs 482 per share.
The total capital infusion from this preferential issue is estimated at approximately Rs 450 crore.
Approval letters were received from NSE and BSE on May 27, 2026, marking a key regulatory milestone.
Company must ensure compliance with SEBI guidelines regarding trade monitoring and lock-in periods for allottees.
👀 What to Watch
Investors should monitor the final allotment and the specific use of the Rs 450 crore proceeds, as this capital infusion supports growth but will result in equity dilution.
Balrampur Chini Q4 FY26: Cane Crushing Up 5.2%, PLA Project Capex at ₹3,080 Crore
Balrampur Chini reported a resilient performance for FY26, crushing 1,043 lakh quintals of cane, a 5.2% increase over the previous year. Despite a ₹30 per quintal hike in sugarcane prices to ₹400, the company maintained stable operations with sugar realizations in UP holding steady at ₹41-₹42 per kg. The company is aggressively pivoting towards its ₹3,080 crore PLA (bioplastic) project, with commissioning expected in Q3 of the current year. Management highlighted that national sugar inventory is at a multi-year low of 4.3 million tonnes, which is expected to support firm domestic pricing.
Key Highlights
Cane crushing increased by 5.2% to 1,043 lakh quintals, outperforming the overall UP market trend.
Projected closing sugar inventory of 4.3 million tonnes is the lowest in recent memory, supporting prices.
PLA project capex revised to ₹3,080 crore with a new lacto-gypsum plant approved at Kumbhi.
Raised ₹450 crore through preferential shares to fund expansion, with ₹193 crore contributed by promoters.
Ethanol segment faces margin pressure due to a 3-year price freeze, but management expects a government revision soon.
👀 What to Watch
Investors should focus on the commissioning of the PLA project in Q3 FY27 as a major diversification catalyst. The low inventory levels and potential ethanol price hikes provide a favorable backdrop for earnings growth in the upcoming quarters.
Balrampur Chini Shareholders Approve Preferential Equity Issue with 99.97% Majority
Balrampur Chini Mills Limited has received shareholder approval for the issuance and allotment of equity shares on a preferential basis during its Extraordinary General Meeting held on May 20, 2026. The special resolution was passed with an overwhelming majority, with 99.97% of the total 15.71 crore votes cast in favor. The voting saw high participation from both promoters and institutional investors, signaling strong support for the company's capital-raising plans. This approval allows the company to move forward with the preferential allotment to strengthen its capital base.
Key Highlights
Special resolution for preferential allotment of equity shares passed with 99.9749% votes in favor.
A total of 15,71,57,518 valid votes were polled, with only 39,451 votes (0.0251%) against the proposal.
Promoter and Promoter Group cast 8,65,45,753 votes, representing 100% support from their category.
Public Institutional investors showed robust support with 99.94% of their 7.00 crore votes in favor.
The meeting was conducted via Video Conferencing in compliance with MCA and SEBI guidelines.
👀 What to Watch
Investors should look for subsequent disclosures regarding the final allotment price and the specific use of proceeds to evaluate the potential for growth versus equity dilution.
Balrampur Chini Mills EGM Approves Rs 450 Crore Preferential Issue to Promoters and Investors
Balrampur Chini Mills Limited held an Extraordinary General Meeting (EGM) on May 20, 2026, to seek shareholder approval for a significant capital raise. The company proposes to raise Rs 450 crore through the preferential allotment of equity shares. The issue is targeted at promoters, the promoter group, and marquee investors, signaling strong internal and external confidence. The final voting results will be disclosed within two working days of the meeting's conclusion.
Key Highlights
Proposed fundraise of Rs 450 crore through preferential allotment of equity shares.
Capital to be raised from promoters, promoter group, and marquee investors.
The meeting was attended by 57 members via video conferencing and other audio-visual means.
Lead Independent Director Dr. Indu Bhushan chaired the proceedings as the CMD was an interested party.
Voting results and Scrutinizer’s Report to be submitted to stock exchanges within two working days.
👀 What to Watch
Investors should look out for the final voting results and the specific allotment price to assess the dilution impact. The participation of marquee investors alongside promoters is generally a bullish signal for the company's growth prospects.
Balrampur Chini Q4 FY26: Revenue up 6.7%, Net Profit down 30% on High Cane Costs
Balrampur Chini Mills reported a 6.67% YoY increase in Q4 FY26 revenue to ₹1,603.99 crore, but net profit dropped 30.25% to ₹157.23 crore. Profitability was severely impacted by an 8% hike in sugarcane prices to ₹400/qtl and stagnant ethanol procurement prices. For the full year FY26, revenue grew 15.8% to ₹6,271.15 crore, while EBITDA saw a modest 5.26% rise. The company is proceeding with a ₹3,080 crore PLA plant and a ₹450 crore preferential equity fundraise to support expansion.
Key Highlights
Q4 FY26 Revenue rose 6.67% to ₹1,603.99 crore, but EBITDA declined 22.03% to ₹284.79 crore.
Sugarcane prices were hiked by ~8% YoY to ₹400/qtl by the U.P. Govt, significantly compressing margins.
Distillery segment remained subdued as ethanol procurement prices have not increased for three consecutive years.
Board approved raising ₹450 crore via preferential equity shares, with promoters contributing ₹193 crore.
The 80,000-ton PLA plant is on track for Q3FY27 with a revised total capex of ₹3,080 crore.
👀 What to Watch
Investors should monitor the margin pressure from rising input costs and the lack of ethanol price hikes which are offsetting volume growth. The long-term outlook depends on the successful commissioning of the high-capex PLA plant in late 2026.
Balrampur Chini Re-appoints Key Leadership and Approves FY26 Audited Financial Results
Balrampur Chini Mills' Board has approved the audited financial results for the year ended March 31, 2026, confirming a clean audit report with an unmodified opinion. A significant leadership decision was made to re-appoint Mr. Vivek Saraogi as Chairman and Managing Director for a 5-year term beginning April 2027. Ms. Avantika Saraogi, a fourth-generation promoter, was also re-appointed as Executive Director for 5 years starting January 2027. These moves ensure management stability as the company pursues its diversification into bio-plastics and circular economy initiatives.
Key Highlights
Re-appointment of Mr. Vivek Saraogi as CMD for a 5-year term starting April 1, 2027.
Re-appointment of Ms. Avantika Saraogi as Executive Director for a 5-year term starting January 1, 2027.
Approval of Audited Financial Results for FY26 with an unmodified audit opinion from Lodha & Co LLP.
Re-appointment of M/s. Mani & Co. as Cost Auditors for the financial year 2026-27.
👀 What to Watch
The re-appointment of the core leadership team provides long-term clarity and stability for shareholders. Investors should focus on the company's transition towards a bio-based circular economy led by the current management.
Balrampur Chini Re-appoints Vivek and Avantika Saraogi for 5-Year Leadership Terms
Balrampur Chini Mills has announced the re-appointment of its top leadership, ensuring management stability for the next five years. Mr. Vivek Saraogi will continue as Chairman and Managing Director from April 2027, while Ms. Avantika Saraogi continues as Executive Director from January 2027. The board also approved the audited financial results for FY2026 with an unmodified audit opinion. This move reinforces the company's focus on its circular economy model and new sustainable ventures like the PLA biopolymer project.
Key Highlights
Re-appointment of Mr. Vivek Saraogi as CMD for a 5-year term starting April 1, 2027
Re-appointment of Ms. Avantika Saraogi as Executive Director for a 5-year term starting January 1, 2027
Board approved audited standalone and consolidated financial results for the year ended March 31, 2026
Ms. Avantika Saraogi is spearheading the 'Balrampur Bioyug' PLA biopolymer project for sustainable plastics
M/s. Mani & Co. re-appointed as Cost Auditors for the financial year 2026-27
👀 What to Watch
The re-appointments signal strong promoter commitment and a clear succession path, which reduces governance risk. Investors should maintain their positions while tracking the execution of the new biopolymer business segment.
Balrampur Chini Approves FY26 Results and Re-appoints Key Promoters for 5-Year Terms
Balrampur Chini Mills approved its audited financial results for the quarter and year ended March 31, 2026, receiving an unmodified audit opinion. The Board secured leadership continuity by re-appointing Mr. Vivek Saraogi as CMD and Ms. Avantika Saraogi as Executive Director for five-year terms beginning in 2027. The company is actively diversifying into bio-plastics with its 'Balrampur Bioyug' PLA project, aiming for sustainable growth. These moves signal a stable management environment focused on long-term value addition beyond traditional sugar manufacturing.
Key Highlights
Approved audited standalone and consolidated financial results for the fiscal year ended March 31, 2026.
Re-appointed Mr. Vivek Saraogi as Chairman and Managing Director for a 5-year term starting April 2027.
Re-appointed Ms. Avantika Saraogi as Executive Director for a 5-year term starting January 2027.
Confirmed the launch of 'Balrampur Bioyug', India's first PLA biopolymer brand for bio-plastics.
Auditors provided an unmodified opinion on the financial statements, ensuring reporting integrity.
👀 What to Watch
Investors should view the management continuity as a positive sign for the execution of the new PLA project. Monitor the specific financial growth in the distillery and biopolymer segments once full results are analyzed.
Balrampur Chini's PLA Study Confirms 94% Microplastic Degradation in 180 Days
Balrampur Chini Mills (BCML) announced results from a government-backed study confirming that Poly Lactic Acid (PLA) microplastics degrade significantly in Indian soil. The study observed particle counts dropping from 287 to 18 per kg over 180 days, whereas conventional plastics showed no reduction. This scientific validation supports BCML's strategic diversification into the bioplastics sector, where it is currently setting up India's first 80,000 TPA PLA plant. The findings are expected to influence future regulatory frameworks in favor of compostable polymers, enhancing the commercial outlook for BCML's upcoming production.
Key Highlights
PLA microplastics reduced from 287 particles/kg to 18 particles/kg within 180 days, showing near-complete degradation.
Conventional fossil-based plastics showed almost no reduction in microplastics over the same 6-month period.
The study was conducted by a premier institution under the Ministry of Chemicals & Fertilizers, Government of India.
BCML is currently establishing India's first PLA plant with a significant capacity of 80,000 TPA.
Heavy metal levels in degraded PLA remained within safe international limits, confirming no toxic residue.
👀 What to Watch
Investors should view this as a positive de-risking event for BCML's high-growth bioplastic vertical. Monitor the construction and commissioning timelines of the 80,000 TPA PLA facility as it represents a major non-sugar revenue stream.
